Clinical Trial Update: Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating doxycycline for safety and efficacy in non-ischemic cardiomyopathy; the study was terminated and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Non-ischemic Cardiomyopathy

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Non-ischemic Cardiomyopathy, Systolic Heart Failure (NYHA II-III) | Phase 2 | Status: TERMINATED | Results posted: 2014-08-20